• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of highest risk domestic inspections in the month resulting in a classification of No Action Indicated (NAI)

Dictionary: The number of high-risk product inspections where no objectionable conditions or practices were found during the inspection (or the significance of the documented objectionable conditions found does not justify further FDA action) are classified as No Action Indicated.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber Classified as NAI
Oct 2011N/A691
Nov 2011N/A766
Dec 2011N/A819
Jan 2012N/A697
Feb 2012N/A725
Mar 2012N/A890
Apr 2012N/A596
May 2012N/A615
Jun 2012N/A622
Jul 2012N/A478
Aug 2012N/A607
Sep 2012N/A463

FY 2012 Total: 7,969

Percent of highest risk domestic inspections in the month resulting in a classification of No Action Indicated

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetPercent Classified as NAI
Oct 2011N/A65
Nov 2011N/A61
Dec 2011N/A62
Jan 2012N/A58
Feb 2012N/A59
Mar 2012N/A59
Apr 2012N/A56
May 2012N/A52
Jun 2012N/A52
Jul 2012N/A52
Aug 2012N/A57
Sep 2012N/A56

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.